Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID

Clinical trial NCT06161688 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06161688
Sponsor: Timothy Henrich
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Long COVID Post Acute Sequelae of COVID-19 Post-Acute COVID-19

Start date: 2024-04-09
Primary completion: 2024-12-20
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.